Detail Measurement of Pre-Prandial and Post-Prandial Blood Glucose during Imeglimin (Twymeeg) Treatment-Reference-Cited by-同舟云学术

Detail Measurement of Pre-Prandial and Post-Prandial Blood Glucose during Imeglimin (Twymeeg) Treatment

Published:2023-03-02 Issue:1 Volume:6 Page:40-46
ISSN:2582-0370
Container-title:Asploro Journal of Biomedical and Clinical Case Reports
language:en
Short-container-title:Asp Biomed Clin Case Rep

Author:

Hayashi Kenji¹,Bando Hiroshi²^ORCID,Miki Kazuya¹,Hamai Misaki¹,Yasuoka Tatsuo¹

Affiliation:

1. Hayashi Hospital, Tokushima, Japan

2. Hayashi Hospital, Tokushima, Japan; Tokushima University/Medical research, Tokushima, Japan; Japan Low Carbohydrate Diet Promotion Association (JLCDPA), Kyoto, Japan

Abstract

Background: Among oral hypoglycemic agents (OHAs), imeglimin (Twymeeg) would be in focus. Case Presentation: The patient in this case is a 58-year-old female with a history of obesity and previous operations for posterior longitudinal ligament ossification. In early September 2022, she developed dizziness and a general feeling of unwellness, leading to a diagnosis of Type 2 Diabetes (T2D) with an HbA1c level of 11.1%. Result: The patient was treated with a low carbohydrate diet (LCD) and Twymeeg, resulting in a significant decrease in HbA1c levels from 11.1% to 9.0%, 6.7%, and 5.9% over the course of three months. Pre-prandial and post-prandial blood glucose levels were measured with great accuracy. Discussion and Conclusion: The administration of Twymeeg was found to be effective in reducing the patient’s HbA1c levels, and the relationship between HbA1c and glucose variability could be further investigated based on these results.

Publisher

Asploro Open Access Publications

Subject

General Medicine

Reference25 articles.

1. Di Bonito P, Licenziati MR, Corica D, Wasniewska M, Di Sessa A, Miraglia Del Giudice E, Morandi A, Maffeis C, Faienza MF, Mozzillo E, Calcaterra V, Franco F, Maltoni G, Valerio G. Which Is the Most Appropriate Cut-Off of HbA1c for Prediabetes Screening in Caucasian Youths with Overweight or Obesity? Int J Environ Res Public Health. 2023 Jan 4;20(2):928. [PMID: 36673682]

2. Arnardóttir E, Sigurðardóttir ÁK, Graue M, Kolltveit BH, Skinner T. Using HbA1c measurements and the Finnish Diabetes Risk Score to identify undiagnosed individuals and those at risk of diabetes in primary care. BMC Public Health. 2023 Jan 31;23(1):211. [PMID: 36721135]

3. Schillinger D, Bullock A, Powell C, Fukagawa NK, Greenlee MC, Towne J, Gonzalvo JD, Lopata AM, Cook JW, Herman WH. The National Clinical Care Commission Report to Congress: Leveraging Federal Policies and Programs for Population-Level Diabetes Prevention and Control: Recommendations from the National Clinical Care Commission. Diabetes Care. 2023 Feb 1;46(2):e24-38. [PMID: 36701595]

4. ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D, Johnson EL, Kahan S, Khunti K, Leon J, Lyons SK, Perry ML, Prahalad P, Pratley RE, Seley JJ, Stanton RC, Gabbay RA, on behalf of the American Diabetes Association. 1. Improving Care and Promoting Health in Populations: Standards of Care in Diabetes-2023. Diabetes Care. 2023 Jan 1;46(Supple 1):S10-18. [PMID: 36507639]

5. Thornton-Swan TD, Armitage LC, Curtis AM, Farmer AJ. Assessment of glycaemic status in adult hospital patients for the detection of undiagnosed diabetes mellitus: A systematic review. Diabet Med. 2022 Apr;39(4):e14777. [PMID: 34951710]